Median (range) GSTP1-1 cyst fluid concentrations (ng/mL) by clinicopathologic parameters and of patients with EOC (n = 56)
| n (%) | Cyst fluid median | GSTP1-1 (range) | P | |
|---|---|---|---|---|
| FIGO stage | 0.010* | |||
| I + II | 27 (48) | 162 | (10-1,302) | |
| III + IV | 28 (50) | 703 | (10-32,695) | |
| Unknown | 1 (2) | |||
| Tumor grade | 0.044* | |||
| Low-grade | 14 (25) | 89 | (10-1,302) | |
| High-grade | 37 (66) | 448 | (10-32,695) | |
| Unknown | 5 (9) | |||
| Histology | 0.264† | |||
| Serous | 24 (43) | 224 | (10-25,963) | |
| Mucinous | 15 (27) | 114 | (10-32,695) | |
| Endometrioid | 12 (21) | 447 | (28-3,583) | |
| Other‡ | 5 (9) | 881 | (362-2,384) | |
| Residual tumor | 0.301* | |||
| <1 cm | 38 (68) | 299 | (10-3,583) | |
| ≥1 cm | 18 (32) | 617 | (10-32,695) | |
| Malignant cells in ascites | 0.101* | |||
| No | 25 (45) | 162 | (12-13,020) | |
| Yes | 28 (50) | 535 | (10-32,695) | |
| Unknown | 3 (5) | |||
| Preoperative CA 125 | 0.010* | |||
| ≤126 U/mL | 27 (48) | 114 | (10-960) | |
| >126 U/mL | 26 (47) | 594 | (10-32,695) | |
| Unknown | 3 (5) | |||
| Total | 56 (100) | 383 | (10-32,695) |